Thomas Reilly
Director of Finance/CFO chez AMARIN CORPORATION PLC
Fortune : 191 890 $ au 31/03/2024
Profil
Thomas Reilly is currently the CFO, Executive VP, Head-Global HR & Finance at Amarin Corp.
Plc.
Previously, he worked as the Head-Finance Medicines Business at Allergan, Inc. and as the Chief Financial & Accounting Officer at CARA Therapeutics, Inc. He completed his undergraduate degree at Manhattan College and holds an MBA from Seton Hall University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AMARIN CORPORATION
0,06% | 20/02/2024 | 215 365 ( 0,06% ) | 191 890 $ | 31/03/2024 |
Postes actifs de Thomas Reilly
| Sociétés | Poste | Début |
|---|---|---|
| AMARIN CORPORATION PLC | Director of Finance/CFO | 20/06/2022 |
Anciens postes connus de Thomas Reilly
| Sociétés | Poste | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Director of Finance/CFO | 15/06/2022 |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
Formation de Thomas Reilly
| Manhattan College | Undergraduate Degree |
| Seton Hall University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
